News
GMS and Centers for Personalized Medicine in Germany in new collaboration in precision medicine
Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM) in Germany, one of Europe’s leading centers in personalized medicine, will intensify the collaboration between the two organizations under the joint Memorandum of Understanding (MoU). The MoU...
Targeted treatment helped child with neuroblastoma
Researchers at Karolinska Institutet and the University of Gothenburg have found another piece of the puzzle in the treatment of the childhood cancer neuroblastoma. A new case report, published in JCO Precision Oncology, describes the successful targeted treatment of...
GMS and France Genomic Medicine Initiative partnership in precision medicine
On October 14th, the Director and CEO for the French National Alliance for Life Sciences and Health, Gilles Bloch, visited Genomic Medicine Sweden, hosted by Karolinska Institutet´s President Ole Petter Ottersen. During the visit Gilles Bloch, Director of the French...
Sweden launches testbed for clinical trials in cancer care
Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient organizations to create an innovation milieu that facilitates the introduction of more precise prevention...
Significant nationwide investment in precision medicine
The Swedish national infrastructure Genomic Medicine Sweden (GMS) will receive an additional SEK 220 million investment. The investment will facilitate the continued introduction of precision medicine into Swedish healthcare, so that every individual in Sweden has...
Precision medicine new opportunity for complex diseases
New review article looks at readiness prior to the implementation of genomics-based precision medicine in complex diseases. The extensive work has been led by researchers at Karolinska Institutet and Lund University and has been carried out together with some 30...
Common lessons learned from the start-up of precision medicine initiatives
Over recent years, a large number of national and regional initiatives in the field of precision medicine have been established in Europe. In an overview published in Seminars in Cancer Biology, Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM)...
GMS’s ambitions for the next 10 years
Genomic Medicine Sweden (GMS) highlights vital aspects for the successful introduction of precision medicine into Swedish healthcare in its Strategy Plan 2021–2030. In Strategy Plan 2021–2030, GMS presents its ambitions for the introduction of precision medicine into...